First, on behalf of Equity.Guru: Legalization day was a fire sale. Some provinces sold more than others. Alberta made $730,000 worth of sales on their first day. Nunavut’s sales…
IAN.C
Had a conversation on the phone with Stephen Pynn, VP of Corporate Devs at Pure Global (PURE.V) this week that got me thinking. Pure has had an up and down…
A week ago, US dispensary roll-up play MedMen (MMEN.C) closed an $86m financing and a $99.95m loan to help them complete a $682m deal to buy PharmaCann, which has…
In news that pushed MedMen’s (MMEN.C) share price to new highs, the red shirt crew have announced they’re buying US based Pharmacann LLC for $682 million… or, rather, $682…
IAnthus Capital (IAN.C) continues to show strong growth, bucking downward industry trends and market volatility, with a surging share-price. The company’s successful expansion into the enormous US market, paired…
iAnthus’ (IAN.C) reports strong revenue growth in Q2, in addition to respectable cash assets and the successes of its east-coast dispensaries. The company’s share price continues trending upwards at a…
According to a September 7, 2018 CTV News report, physicians in Canada are seeing “an increase in emergency room visits by patients overdosing on cannabis.” “Edibles pose a high…
I’ve written this story three times in as many days, because every time I get to the bottom and am ready to post, the valuations of everything seem to…
Julius Kalcevich, CFO of iAnthus Capital Holdings (IAN.C), discussed his company’s future in the changing American cannabis industry at Canaccord Genuity’s 38th Annual Global Growth Conference today in Boston,…
I missed it. Y’all can point and laugh, but when folks said to me a year ago, “Hey, what about iAnthus Capital?” (IAN.C), I shrugged and said, “I can’t…